Navigation Links
American Skin Association Announces New Member Of The Board J. Michael Pearson And New Education Council Member Ryan Weldon Of Valeant Pharmaceuticals International, Inc.
Date:4/24/2013

NEW YORK, April 24, 2013 /PRNewswire/ -- Howard P. Milstein, Chairman of American Skin Association (ASA), announced that J. Michael Pearson , Chairman and CEO of Valeant Pharmaceuticals International, Inc., has become a member of the ASA Board of Directors.

ASA's main mission is to advance research, champion skin health and drive public awareness regarding skin disease and melanoma/skin cancer. Through its national program of grants and awards, ASA has committed approximately $9 million to underwriting research by a new generation of scientists trained in dermatology and dedicated to overcoming the most serious forms of skin disease.

" Mike Pearson brings a tremendous wealth of experience to the Board. I look forward to working with him as we continue funding research, educating future generations on skin health and furthering the goal of defeating melanoma, skin cancer, and other skin diseases," said Howard P. Milstein .

"I am honored to become a part of ASA," Mike Pearson said. "Their efforts on behalf of skin disease and skin cancer have had a tremendous effect on increasing public awareness and their commitment to dermatology research has been a key driver in encouraging earlier diagnoses and new therapies. I look forward to working with the rest of the Board of Directors upholding and promoting the ASA's mission."

ASA also announced that Ryan Weldon , Executive Vice President and Company Group Chairman of the U.S. Dermatology Operations at Valeant Pharmaceuticals International, Inc., has become a member of its Education Council.  Weldon was appointed as an Executive Officer at Valeant in December 2012. Prior to that, he served as Vice President and General Manager of Aesthetics and General Manager of U.S. Neurology and Other at Valeant.

"Many of Valeant's acquisitions were once, or still are, some of the world's leading brands, transforming Valeant into one of the world's most important suppliers of dermatology drugs," said Humberto C. Antunes , President and CEO of Galderma and Co-Chair of ASA's Education Council.

ABOUT AMERICAN SKIN ASSOCIATION
Led by patients, families and their advocates working with the nation's foremost physicians and scientists, American Skin Association has evolved into an increasingly influential leader in efforts to defeat melanoma and other serious forms of skin disease. For over two decades, its mission has remained to advance research, champion skin health - particularly among young people, and raise public awareness about skin cancer and disease. For more information, visit www.americanskin.org.


'/>"/>
SOURCE American Skin Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Shalom Jacobovitz Named CEO of American College of Cardiology
2. Nucletron, an Elekta company, to Debut New Flexitron Brachytherapy Afterloading Platform at 2013 American Brachytherapy Society Meeting
3. Johnson & Johnson Announces Sale of Elan American Depositary Shares to Elan
4. Zacks Investment Ideas feature highlights: PharMerica, First Defiance Financial, American Railcar Industries and Big 5 Sporting Goods
5. Joint Statement On The Presidents Budget From The American Society Of Clinical Oncology, Community Oncology Alliance, ION Solutions and The US Oncology Network
6. Kinex Pharmaceuticals Chief Scientific Officer, Dr. David Hangauer, named the American Cancer Societys 2013 Honoree for its Cuisine for a Cure event
7. Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US Congress
8. Novocure Presents Preclinical Data at the American Association for Cancer Research (AACR)
9. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
10. Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting
11. American Association for Homecare Asks Associated Press To Correct Misleading Information In Story On Scooter Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/22/2017)... SAN DIEGO , Sept. 22, 2017 ... ll medical device is now successfully helping those with ... Union. Fibromyalgia diagnosed Amanda in ... getting dressed and washing my hair, experiencing no sleep ... body in painful spasm… I cannot recommend [the AVACEN ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
Breaking Medicine News(10 mins):